Oral IMPACT Powder

What is Oral Impact?

Oral IMPACT® is a powdered enteral nutritional supplement with omega-3 fatty acids, arginine, RNA and soluble fibre. Oral IMPACT® is a nutritionally complete Food for Special Medical Purposes and for use under medical supervision.

What makes Oral Impact so special?

In clinical trials, patients who received Oral IMPACT® orally for at least 5 days prior to surgery developed significantly fewer post-operative infections than those patients who did not. These patients also spent significantly less time in the hospital than those who did not receive IMPACT® prior to surgery.

It is the only preoperative nutritional intervention that has been proven in clinical trials to significantly reduce the rate of post-operative infections.

What is Oral Impact indicated for?

The oral use of IMPACT® is recommended:

Before surgery for all patients undergoing major-elective GI cancer surgery, head and neck cancer surgery, or cardiovascular surgery
Post-operatively or post-injury for select patients at risk for infection who are able to consume an oral diet
For patients with severe pressure ulcers or other chronic wounds

Nutritional Information

References

Supportive Clinical Outcome studies with Oral Impact®

1. Braga M, Gianotti L, Vignali A, Di Carlo V. Preoperative Oral Arginine and n-3 Fatty Acid Supplementation Improves the Immunometabolic Host Response and Outcome after Colorectal Resection for Cancer. Surgery. 2002; 132:805-814.

2. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A Randomized Controlled Trial of Preoperative Oral Supplementation with a Specialized Diet in Patients with Gastrointestinal Cancer. Gastroenterology. 2002; 122:1763-1770.

3. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional Approach in Malnourished Surgical Patients: A Prospective Randomized Study. Arch Surg.2002; 137:174-180.

4. Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp, SH, van Deventer SJ, Ince C, et al. Effect of Preoperative Oral Immune-enhancing Nutritional Supplement on Patients at High Risk of Infection after Cardiac Surgery: A Randomised Placebo-controlled Trial. Lancet. 2001;358:696-701.

5. Braga M et al. Perioperative Immunonutrition in Patients Undergoing Cancer Surgery: Results of a Randomized Double-blind Phase 3 Trial. Arch Surg. 1999;134:428-433.

6. Snyderman CH et al. Reduced Postoperative Infections with an Immune-Enhancing Nutritional Supplement. The Laryngoscope. 1999; 109:915-921.

7. Senkal M et al. Outcome and Cost-effectiveness of Perioperative Enteral Immunonutrition in Patients Undergoing Elective Upper Gastrointestinal Tract Surgery: A Prospective Randomized Study. Arch Surg 1999;134:1309-1316.